StemCells, Inc., 'Winding Down' Its Business; Shareholders Could Be Left in Cold
StemCells, Inc., a publicly traded firm that once held close ties to the $3 billion California stem cell agency, this morning said that it was going to close its doors and that its shareholders may not receive a dime in the liquidation.
The announcement was buried deep in a press release focusing largely on the termination of the firm's spinal cord injur…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.